From lab bench to boardroom — Panacea Stars helps founders build faster, de-risk earlier, and scale globally. We turn breakthrough Bio-AI science into ventures that reshape healthcare, from early insight to clinical-commercial readiness. Whether you’re starting with an idea or proof-of-concept, you can join us at the stage that fits. Are you a pre-idea or early stage researcher? Apply for 𝐈𝐠𝐧𝐢𝐭𝐞, designed for those shaping early conviction around a scientific idea or unmet clinical need—this is the inflection point where research meets opportunity. Do you have IP or an early proof of concept? Apply for 𝐒𝐭𝐫𝐢𝐝𝐞 and get ready to de-risk, sharpen product-clinic fit, and prepare for institutional capital —this is where we engineer ventures to be investment-grade. Learn more at panacea-stars.com Apply now → https://lnkd.in/e8DvBKRe
Panacea
Investment Management
Oxford, Oxfordshire 5,656 followers
Panacea is a coordinated force for healthcare transformation.
About us
Panacea is a coordinated force for healthcare transformation. We are a system of convergence, purpose-built to redesign how breakthrough science becomes real-world impact. We operate across venture building, capital deployment, and ecosystem design to engineer a healthier, fairer, and faster future.
- Website
-
http://www.panacea-hq.com
External link for Panacea
- Industry
- Investment Management
- Company size
- 11-50 employees
- Headquarters
- Oxford, Oxfordshire
- Type
- Privately Held
- Founded
- 2014
- Specialties
- AI, Venture Capital, Advanced Pharmaceuticals, Biotech, Medical Technology, Healthtech, Investment, Innovation, Digital Health, and Sustainability
Locations
-
Primary
Magdalen Centre
Oxford Science Park
Oxford, Oxfordshire OX4 4GA, GB
Employees at Panacea
-
Ramana G.
Venture Capital | Life Science & Healthcare
-
Monika Kott
Pioneering the Future of BrainTech | Health Tech & Life Sciences Advisor | Early-Stage Investor | Entrepreneur
-
Mina Elisha Bekheet
CEO & Managing Partner at Panacea
-
Ross Thomson
Doctor at Barts Heart Centre | Clinical Research Fellow at QMUL | Clinical Principal at Panacea Innovation | Ex-BCG
Updates
-
Panacea@Oxford: In partnership with Saïd Business School, University of Oxford, to build the world’s leading healthcare ventures. Designed to convert University of Oxford’s deepest scientific strengths into globally impactful Bio-AI breakthroughs—taking ideas from lab to clinic. Read more in the comments.
Today we launch Panacea @ Oxford with the Oxford Saïd Entrepreneurship Centre, Saïd Business School, University of Oxford. Backing Oxford’s brightest minds to turn frontier science into ventures that reshape healthcare. Maria Zubeldia Diaz, Thomas Hellmann, Pinar Ozcan, Ahmed Adel Saad, Callum Usher-Dodd and the Saïd Business School, University of Oxford team - bridging research and business. A world class team. Prof. Constantin Coussios OBE FREng FMedSci, joins as Clinical Entrepreneur Champion. He’s walked the journey - very successfully - and now humbly continues to help others follow it. Oxford already leads the UK in spinouts - led by great peers and colleagues. Oxford University Innovation, EnSpire Oxford and champions across the University provide the foundations. Oxford Science Enterprises brings Oxford-native capital and great expertise. The ecosystem has never been stronger. University of Oxford helped shaping me as a scientist, entrepreneur and investor. I first pitched Panacea here - on a soapbox. Years later, we're back on the other side. From dreaming spires to Bio-AI breakthroughs. To building new Panaceas 🥂. https://lnkd.in/eQvXBSj7
-
-
Panacea reposted this
Today I publicly share the Panacea Manifesto. A lens — refined over years of building and investing. At its core is Convergent Intelligence — biology, AI, and human insight. Alone, each is powerful. Together, transformative. This is our Definite Convergence Thesis. Innovation must be orchestrated, not left to chance. We’re eyeing the new Bio-AI industrial revolution — a $4T market. Healthcare is being reorganised. Research. Diagnostics. Therapeutics. Delivery. The opportunity lies in the pre-company gap — bridging the chasm between scientific insight and commercial outcome. Together, a Panacea is being built. To shape a fairer, faster, healthier world. Panacea. Truly invested in the future of healthcare. 🔗 Read the Manifesto → https://lnkd.in/eFpF32vj
-
Panacea reposted this
Today we reveal a new Panacea chapter. A refreshed brand. A refined mission. We rarely lift the curtain. But this moment matters - to show what’s built, and where we’re heading. Panacea has become a coordinated force of builders, scientists, clinicians, and investors. 400+ ventures. £2bn+ in value. We’ve institutionalised our thesis: when forces converge - biology, AI, and great minds - breakthroughs happen. To innovate with impact - discovery becomes treatment. To build with persistence - vision becomes company. To invest with conviction - ambition becomes founder. None of this is possible without the team. The founders who trust us. The partners who stand with us. The investors who share our conviction. Panacea . Truly invested in the future of healthcare. www.panacea-hq.com
-
We were thrilled to co-host “Innovators Meet Talent” with Imperial College London last week. Thank you to the team at Imperial for partnering with us and to all the speakers and startups who shared their stories. Celestin de Wergifosse Andreia Bernardo James Howard Marie-Victoire Sjøthun
Last night’s “Innovators Meet Talent” at Imperial College London #ScaleSpace was a fantastic gathering of ideas and energy. A big thankyou to Panacea Innovation for collaborating and to all the start ups for sharing their inspiring journeys. Definitely look forward to what we can build next. Mina Elisha Bekheet Dr Aaron M. Lett Christian Pernstich Andreia Bernardo Rafiq Hasan 🍵 Tina Chen Lily Sabol Afraa Alzoubi Yiling GUO Amin Izadyar #Innovation #ImperialScaleSpace #Startups #PanaceaInnovation #Networking #FutureTalent
-
-
-
-
-
+1
-
-
‼️ Applications for Action Spring/Summer 2025 close this Friday at midnight. Apply now: https://lnkd.in/eFsRDZFg
📣 Attention: applications are now open for our Spring/Summer 2025 #Panacea Stars Action Programme! 📣 💡Action is designed to spark your entrepreneurial appetite and provide an introduction to translating cutting-edge science into products and early-stage companies that can deliver meaningful impact to patients. We offer support to innovators in three streams: CardioStars: in partnership with the British Heart Foundation, for those working to prevent, diagnose or treat cardiovascular disease. OncoStars: in partnership with Cancer Research UK (CRUK) and Cancer Research Horizons, for those working to prevent, diagnose, or treat cancer. LifeSciStars: in partnership with Bio-Rad Laboratories, for those working in the fields of life sciences and diagnostics. 🧬 This 4-week programme provides an accessible crash course in research translation and commercialisation. It includes a one-day bootcamp in London; focused virtual sprint weeks; wide-ranging support in scientific, clinical, financial, and legal aspects; access to industry leaders; and exposure to a community of like-minded innovators. 🌟 We've worked with 400+ teams to create £1.5bn+ in value. The best participants can advance to our later stage venture builder programme - Develop - and ultimately to gain investment from Panacea Capital. 🤝 In partnership with: Cancer Research UK (CRUK) , Cancer Research Horizons, British Heart Foundation, Bio-Rad Laboratories, McKinsey & Company, J A Kemp and Taylor Wessing UK. ➡️ Apply here by 16 May: https://lnkd.in/eFsRDZFg
-
-
Panacea reposted this
Just a few days till applications for our #OncoStars programme close 👀 This is a great opportunity to explore how to translate your #CancerResearch into an investment-ready venture to deliver impact for patients. This 4-week programme, run by Panacea Innovation, Cancer Research UK (CRUK) and us, includes a one-day bootcamp and follow-on sprints focused on product-market fit and translational awareness, supported by experienced mentors. 🔬 For researchers at any stage 🆕 No commercial experience needed ⏰ Deadline: 16 May Link to apply in the comments 👇 Juliana Callaghan, Alessia Errico PhD MBA , Cancer Research UK Science and Innovation #OnMyHorizon #VentureBuilding #TranslationalResearch #LifeSciences #PanaceaStars
-
-
📣 Attention: applications are now open for our Spring/Summer 2025 #Panacea Stars Action Programme! 📣 💡Action is designed to spark your entrepreneurial appetite and provide an introduction to translating cutting-edge science into products and early-stage companies that can deliver meaningful impact to patients. We offer support to innovators in three streams: CardioStars: in partnership with the British Heart Foundation, for those working to prevent, diagnose or treat cardiovascular disease. OncoStars: in partnership with Cancer Research UK (CRUK) and Cancer Research Horizons, for those working to prevent, diagnose, or treat cancer. LifeSciStars: in partnership with Bio-Rad Laboratories, for those working in the fields of life sciences and diagnostics. 🧬 This 4-week programme provides an accessible crash course in research translation and commercialisation. It includes a one-day bootcamp in London; focused virtual sprint weeks; wide-ranging support in scientific, clinical, financial, and legal aspects; access to industry leaders; and exposure to a community of like-minded innovators. 🌟 We've worked with 400+ teams to create £1.5bn+ in value. The best participants can advance to our later stage venture builder programme - Develop - and ultimately to gain investment from Panacea Capital. 🤝 In partnership with: Cancer Research UK (CRUK) , Cancer Research Horizons, British Heart Foundation, Bio-Rad Laboratories, McKinsey & Company, J A Kemp and Taylor Wessing UK. ➡️ Apply here by 16 May: https://lnkd.in/eFsRDZFg
-
-
⏳ Last chance! Applications for Develop Spring/Summer 2025 close this Friday at midnight. Apply now! 👉 https://lnkd.in/dvgecpX
🚀 Attention life science and health tech entrepreneurs: applications are still open for the Spring/Summer 2025 #PanaceaStars Develop Programme! 💡 Whether you're working in digital health, medtech, therapeutics, diagnostics, or platform technologies, this is your chance to transform your breakthrough idea into a successful venture. We support founders at every stage, from proof-of-concept to post-Series A. 🧬 Over 8 weeks, you'll gain commercial and investment readiness through tailored mentorship, strategic resources, and access to industry leaders. Our programme will help you refine your vision with structured sprints, guided experimentation, and a community of like-minded entrepreneurs. 🌟 Be part of the 400+ teams that have built £1.5bn+ in value. Top ventures have the opportunity to secure pre-seed and seed funding with Panacea Ventures. 🤝 In partnership with: Cancer Research UK (CRUK), Cancer Research Horizons, British Heart Foundation, Bio-Rad Laboratories, Danaher Corporation, McKinsey & Company, AstraZeneca, GSK, IBM, J A Kemp, and Taylor Wessing UK. ➡️ Apple here by 28 February: https://lnkd.in/dvgecpX
-
🚀 Attention life science and health tech entrepreneurs: applications are still open for the Spring/Summer 2025 #PanaceaStars Develop Programme! 💡 Whether you're working in digital health, medtech, therapeutics, diagnostics, or platform technologies, this is your chance to transform your breakthrough idea into a successful venture. We support founders at every stage, from proof-of-concept to post-Series A. 🧬 Over 8 weeks, you'll gain commercial and investment readiness through tailored mentorship, strategic resources, and access to industry leaders. Our programme will help you refine your vision with structured sprints, guided experimentation, and a community of like-minded entrepreneurs. 🌟 Be part of the 400+ teams that have built £1.5bn+ in value. Top ventures have the opportunity to secure pre-seed and seed funding with Panacea Ventures. 🤝 In partnership with: Cancer Research UK (CRUK), Cancer Research Horizons, British Heart Foundation, Bio-Rad Laboratories, Danaher Corporation, McKinsey & Company, AstraZeneca, GSK, IBM, J A Kemp, and Taylor Wessing UK. ➡️ Apple here by 28 February: https://lnkd.in/dvgecpX